Central Nervous System Serotonin Function and Cardiovascular Responses to Stress
Redford B. Williams, MD,
Douglas A. Marchuk, PhD,
Kishore M. Gadde, MD,
John C. Barefoot, PhD,
Katherine Grichnik, MD,
Michael J. Helms, BS,
Cynthia M. Kuhn, PhD,
James G. Lewis, PhD,
Saul M. Schanberg, MD, PhD,
Mark Stafford-Smith, MD,
Edward C. Suarez, PhD,
Greg L. Clary, MD,
Ingrid K. Svenson, BSc and
Ilene C. Siegler, PhD
From the Departments of Psychiatry and Behavioral Sciences (R.B.W., J.C.B., G.L.C., K.M.G., M.J.H., I.C.S., E.C.S.), Anesthesiology (K.G., M.S.-S.), Pharmacology and Cancer Biology (C.M.K., S.M.S.), Pathology (J.G.L.), and Genetics (D.A.M., I.K.S.), Duke University Medical Center, Durham, North Carolina.

View larger version (33K):
[in a new window]
|
Fig. 1. CSF 5HIAA levels (mean ± SEM) in subjects with l/l, l/s, and s/s 5HTTLPR genotypes. Subjects with l/l and l/s do not differ, and level of l/l and l/s subjects combined is higher than that of s/s subjects. p = .006, one-way ANOVA.
|
|

View larger version (25K):
[in a new window]
|
Fig. 2. A, MAP (mean ± SEM) during rest and stress periods. Subjects with high (Hi, based on median split) levels of 5HIAA show a larger increase in MAP than subjects with low (Lo) 5HIAA levels (two-way ANOVA, group-by-period interaction: p < .001). B, Subjects with l/l or l/s genotype show larger MAP increases than s/s subjects (two-way ANOVA, group-by-period interaction: p < .0001).
|
|
Copyright © 2001 by the American Psychosomatic Society